Roxithromycin 150mg (Generic)

WHAT IS THIS MEDICATION FOR?

Roxithromycin 150mg (Generic) is a semi-synthetic macrolide antibiotic, prescribed for respiratory tract, urinary and soft tissue infections.

HOW DOES IT WORK?

Roxithromycin is used to treat certain bacterial infections of the ear, nose, throat, lungs or skin.

HOW TO USE?

It comes as a tablet to take by mouth, on an empty stomach. Adult: PO- The recommended dose is 150 mg twice daily or 300 mg once daily for 5-10 days.

SIDE EFFECTS:

You may have diarrhoea, nausea and stomach discomfort while being treated with Roxithromycin. These side effects are usually mild and temporary. If you have diarrhoea, drink lots of water to replace the fluids lost. However, if you have severe diarrhoea or diarrhoea with severe stomach cramps or bloody stools, alert your doctor.

WHAT TO DO IF I MISS A DOSE?

Call your doctor to find out what to do.

PRECAUTIONS:

Alert your doctor if you have a history of allergic reactions (breathlessness, rashes, swollen mouth or eyes) to similar antibiotics such as clarithromycin, erythromycin or any other macrolide antibiotics.

WHEN DO I NEED TO SEEK MEDICAL HELP?

If you think there was an overdose, call your local poison control center or ER right away. Signs of a very bad reaction to the drug. Side effect or health problem is not better or you are feeling worse.

CAN I TAKE IT WITH OTHER MEDICINES?

Sometimes drugs are not safe when you take them with certain other drugs and food. Taking them together can cause bad side effects. Be sure to talk to your doctor about all the drugs you take.

FOOD RESTRICTIONS:

Avoid Alcohol.

HOW TO STORE:

Store in a cool, dry place away from the reach of children. Medicines must not be used past the expiry date.

PREGNANCY CATEGORY:

Category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THERAPEUTIC CLASSIFICATION:

Macrolides.